212 studies found for:    rsv
Show Display Options
Rank Status Study
1 Active, not recruiting RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: Saline Placebo (0.5mL injection);   Drug: RSV F vaccine (0.5mL injection)
2 Recruiting Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Drug: VXA-RSV-f Oral Vaccine;   Drug: VXA Placebo Tablets
3 Active, not recruiting Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women
Condition: Respiratory Synctial Virus Infections
Interventions: Biological: RSV vaccine GSK3003895A (formulation 1);   Biological: RSV vaccine GSK3003898A (formulation 2);   Biological: RSV vaccine GSK3003899A (formulation 3);   Biological: Boostrix
4 Active, not recruiting A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: RSV-F Vaccine;   Biological: Phosphate Buffer Placebo
5 Completed RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections.
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: PanAd3-RSV given intra-nasally (high dose);   Biological: MVA-RSV given by intra-muscular injection (high dose);   Biological: PanAd3-RSV given by intra-muscular injection (high dose);   Biological: PanAd3-RSV given intranasally (low dose);   Biological: MVA-RSV given by intra-muscular injection (low dose);   Biological: PanAd3-RSV given by intra-muscular injection (low dose)
6 Recruiting A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Participants
Condition: Healthy Participants
Interventions: Biological: Ad35.RSV.FA2;   Biological: Ad26.RSV.FA2;   Drug: Placebo
7 Completed Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALN-RSV01;   Drug: Normal Saline
8 Completed Placebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly Adults
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: RSV-F Vaccine;   Biological: Saline Placebo
9 Recruiting A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV F vaccine with adjuvant;   Biological: Formulation buffer
10 Recruiting A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine
Condition: Respiratory Syncytial Virus
Interventions: Biological: DPX-RSV(A);   Biological: RSV(A)-Alum;   Other: Placebo
11 Completed Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALN-RSV01;   Drug: normal saline
12 Recruiting A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers
Conditions: Respiratory Syncytial Viruses;   Respiratory Tract Infections
Interventions: Biological: Ad26.RSV.FA2;   Biological: Ad35.RSV.FA2;   Drug: Placebo
13 Active, not recruiting Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: MVA BN RSV;   Other: Placebo
14 Recruiting To Evaluate the Safety and Ability of the Medicine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: RSV F subunit vaccine-Low dosage; no adjuvant;   Biological: RSV F subunit vaccine-Medium dosage; no adjuvant;   Biological: RSV F subunit vaccine-High dosage; no adjuvant;   Biological: RSV F subunit vaccine-Low dosage; with aluminum hydroxide;   Biological: RSV F subunit vaccine-Medium dosage; with aluminum hydroxide;   Biological: RSV F subunit vaccine-High dosage; with aluminum hydroxide;   Biological: RSV F subunit vaccine-Low dosage; with MF59;   Biological: RSV F subunit vaccine-Medium dosage; with MF59;   Biological: RSV F subunit vaccine-High dosage; with MF59;   Biological: Placebo-Sterile Saline
15 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
16 Active, not recruiting Safety and Immunogenicity of the RSV-F Vaccine in Older Adults Previously Treated With the Same Vaccine or Placebo in the Prior Year.
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: RSV-F Vaccine;   Biological: Phosphate Buffer Placebo
17 Not yet recruiting Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV LID ΔM2-2 1030s vaccine;   Biological: Placebo
18 Completed
Has Results
Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis
Condition: Respiratory Syncytial Virus (RSV)
Intervention:
19 Completed RSV-F Vaccine Dose Ranging Study in Young Women
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Biological: Low dose RSV-F Vaccine with Adjuvant;   Biological: Low dose RSV-F Vaccine without Adjuvant;   Biological: High dose RSV-F Vaccine with Adjuvant;   Biological: High dose RSV-F Vaccine without Adjuvant;   Biological: Low dose RSV-F Vaccine with Adjuvant [Bedside Mixing];   Biological: Placebo
20 Completed Azithromycin to Prevent Wheezing Following Severe Respiratory Syncytial Virus (RSV) Bronchiolitis
Condition: RSV Bronchiolitis
Intervention: Drug: Azithromycin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years